

|
|
基本情報 |
|
氏名 |
窪木 厚人 |
氏名(カナ) |
クボキ アツヒト |
氏名(英語) |
Kuboki Atsuhito |
所属 |
生命科学部 生物科学科 |
職名 |
准教授 |
researchmap研究者コード |
1000311530 |
researchmap機関 |
岡山理科大学 |
Chemo-enzymatic Synthesis of Ester-Linked Docetaxel-Glycoside Conjugate and its Drug Delivery System Using Hybrid-Bio-Nanocapsules Targeted With Trastuzumab and Cetuximab
Yuya Fujitaka, Hiroki Hamada, Hatsuyuki Hamada, Noriyoshi Masuoka, Kei Shimoda, Daisuke Uesugi, Takafumi Iwaki, Atsuhito Kuboki, Kohji Ishihara, Yuya Kiriake
Synthesis of ester-linked glucoside conjugate of docetaxel, 7-propionyldocetaxel 3"-O-α-D-glucopyranoside, was carried out by chemo-enzymic procedures. The EE and LE values for hybrid-bio-nanocapsules of 7-propionyldocetaxel 3"-O-α-D-glucopyranoside were much improved rather than those of docetaxel. The hybrid-bio-nanocapsules targeted with trastuzumab and cetuximab, which contained 7-propionyldocetaxel 3"-O-α-D-glucopyranoside, showed high in vivo anti-cancer activity, ie, effective suppression of tumor growth, resp.
Natural Product Communications
|